《新股消息》上海上美化妝品再度提交主板上市申請
聯交所文件披露,上海上美化妝品股份有限公司向聯交所提交主板上市申請,摩根大通、中金公司、及中信證券爲聯席保薦人。該公司今年1月中旬曾遞表。
上海上美化妝品是一間多品牌化妝品公司,專注於護膚品及母嬰護理產品的開發、製造及銷售。
目前公司在多個品牌下提供化妝品,主要包括韓束、一葉子和紅色小象等品牌。
根據弗若斯特沙利文報告,於2021年,集團是唯一擁有兩個護膚品牌年零售額均超過15億元人民幣(下同)的國貨化妝品公司。此外,紅色小象於2021年零售額已超過18億元,在中國市場國貨品牌母嬰護理產品中居首。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.